EssilorLuxottica (ESLOY)
(Delayed Data from OTC)
$108.57 USD
0.00 (0.00%)
Updated Jul 16, 2024 03:59 PM ET
1-Strong Buy of 5 1
C Value C Growth B Momentum C VGM
EssilorLuxottica Unsponsored ADR (ESLOY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$119.30 | $119.30 | $119.30 | 9.88% |
Price Target
Only one analyst offered a short-term price target of $119.30 for EssilorLuxottica Unsponsored ADR. This represents an increase of 9.88% from the last closing price of $108.57.
Analyst Price Targets (1 )
Broker Rating
EssilorLuxottica Unsponsored ADR currently has an average brokerage recommendation (ABR) of 2.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ESLOY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/28/2024 | Not Identified | Not Identified | Hold | Hold |
1/29/2024 | UBS | Susy Tibaldi | Hold | Hold |
12/1/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/2/2023 | Not Identified | Not Identified | Strong Sell | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.14 |
ABR (Last week) | 2.14 |
# of Recs in ABR | 7 |
Average Target Price | $119.30 |
LT Growth Rate | 11.40% |
Industry | Medical - Products |
Industry Rank by ABR | 157 of 252 |
Current Quarter EPS Est: | NA |